Standardized SEC financial data for INCYTE CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000879169 · NASDAQ · Services-Commercial Physical & Biological Research.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.67B | $2.99B | $3.39B | $3.70B | $4.24B | $5.14B |
| Cost of revenue | $131.3M | $151.0M | $207.0M | $255.0M | $312.1M | $372.1M |
| Gross profit | $2.54B | $2.84B | $3.19B | $3.44B |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.51B | $2.06B | $2.95B | $3.22B | $1.69B | $3.10B |
| Inventory | $16.4M | $27.9M | $42.0M | $63.0M | $58.9M | $101.1M |
| Total current assets | $2.36B | $3.12B | $4.09B | $4.65B |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$124.6M | $749.5M | $969.9M | $496.5M | $335.3M | $1.41B |
| Capital expenditures | $187.4M | $181.0M | $77.8M | — | — | — |
| Free cash flow | -$312.0M | $568.5M | $892.1M | — |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INCY/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INCY/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $3.93B |
| $4.77B |
| R&D expense | $2.22B | $1.46B | $1.59B | $1.63B | $2.61B | $2.05B |
| SG&A expense | $516.9M | $739.6M | $1.00B | $1.16B | $1.24B | $1.38B |
| Operating income | -$263.7M | $585.8M | $579.4M | $620.5M | $61.4M | $1.51B |
| EBITDA | -$211.9M | $643.6M | $647.3M | $703.2M | $150.6M | $1.61B |
| Interest expense | $2.2M | $1.9M | $2.7M | $2.6M | — | — |
| Pretax income | -$232.2M | $570.4M | $529.1M | $834.2M | $316.6M | $1.66B |
| Income tax | $63.5M | $378.1M | $188.5M | $236.6M | $284.0M | $377.8M |
| Net income | -$295.7M | $948.6M | $340.7M | $597.6M | $32.6M | $1.29B |
| EPS (diluted) | $-1.36 | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 |
Standardized from INCYTE CORP's SEC filings — per-share figures split-adjusted. Full history via the API.
| $3.24B |
| $5.02B |
| Property, plant & equipment | $559.6M | $723.9M | $739.3M | $751.5M | $763.4M | $730.9M |
| Goodwill | $155.6M | $155.6M | $155.6M | $155.6M | $155.6M | $133.0M |
| Total assets | $3.56B | $4.93B | $5.84B | $6.78B | $5.44B | $6.96B |
| Total current liabilities | $631.2M | $854.3M | $1.16B | $1.24B | $1.64B | $1.52B |
| Total liabilities | $949.6M | $1.16B | $1.47B | $1.59B | $2.00B | $1.79B |
| Retained earnings | -$1.73B | -$777.9M | -$437.2M | $160.4M | -$1.07B | $213.8M |
| Total equity | $2.61B | $3.77B | $4.37B | $5.19B | $3.45B | $5.17B |
| — |
| — |
| Investing cash flow | -$269.0M | -$207.7M | -$78.5M | -$207.7M | $157.5M | -$102.6M |
| Financing cash flow | $71.7M | $6.2M | -$794K | -$20.0M | -$2.02B | $101.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | — | — | $0 | $0 | $2.00B | $0 |